These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8148367)

  • 1. 4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats.
    Hegadoren KM; Greenshaw AJ; Baker GB; Martin-Iverson MT; Lodge B; Soin S
    J Psychiatry Neurosci; 1994 Jan; 19(1):57-62. PubMed ID: 8148367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
    Tseng LF; Menon MK; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.
    Martin-Iverson MT; Yamada N; By AW; Lodge BA
    J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine.
    Kaminskas LM; Irvine RJ; Callaghan PD; White JM; Kirkbride P
    Psychopharmacology (Berl); 2002 Mar; 160(2):155-60. PubMed ID: 11875633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The increased release of 3H-5-hydroxytryptamine by d-para-methoxyamphetamine and d-amphetamine in vivo.
    Tseng LF
    Proc West Pharmacol Soc; 1976; 19():136-41. PubMed ID: 1036622
    [No Abstract]   [Full Text] [Related]  

  • 7. Analgesic and behavioral effects of amphetamine enantiomers, p-methoxyamphetamine and n-alkyl-p-methoxyamphetamine derivatives.
    Bustamante D; Díaz-Véliz G; Paeile C; Zapata-Torres G; Cassels BK
    Pharmacol Biochem Behav; 2004 Oct; 79(2):199-212. PubMed ID: 15501295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
    Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
    Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D; Mennini T; Gobbi M
    Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats.
    Lazenka MF; Blough BE; Negus SS
    J Sex Med; 2016 Mar; 13(3):338-49. PubMed ID: 26831817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side-chain monofluorinated analogs of amphetamine and p-chloroamphetamine. Effects on release of dopamine and 5-hydroxytryptamine from rat striatum.
    Coutts RT; Baker GB; Benderly A; McKim HR
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):201-4. PubMed ID: 432436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative potency of amphetamine isomers in causing the serotonin behavioral syndrome in rats.
    Sloviter RS; Damiano BP; Connor JD
    Biol Psychiatry; 1980 Oct; 15(5):789-96. PubMed ID: 7417631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotion induced by non-contingent intracranial electrical stimulation: Dopamine dependence and general characteristics.
    Martin JC; Dougan JD; Wu Q; Stanisz LA; Martyn S; Rokosik S; Garris PA; Farmer-Dougan V
    Behav Processes; 2004 Sep; 67(2):131-46. PubMed ID: 15240051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1999 Oct; 291(1):19-30. PubMed ID: 10490882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats.
    Mague SD; Andersen SL; Carlezon WA
    Biol Psychiatry; 2005 Jan; 57(2):120-5. PubMed ID: 15652869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacology of amphetamines.
    van Rossum JM
    Psychiatr Neurol Neurochir; 1972; 75(3):165-78. PubMed ID: 4625012
    [No Abstract]   [Full Text] [Related]  

  • 17. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
    Miller DK; Dopheide MM; Smith SM; Casteel SW
    Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
    Miller RT; Lau SS; Monks TJ
    Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
    Rothman RB; Baumann MH; Dersch CM; Romero DV; Rice KC; Carroll FI; Partilla JS
    Synapse; 2001 Jan; 39(1):32-41. PubMed ID: 11071707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical as well as novel antipsychotic drugs increase self-stimulation threshold in the rat--similar mechanism of action?
    Flagstad P; Arnt J; Olsen CK
    Eur J Pharmacol; 2006 Aug; 544(1-3):69-76. PubMed ID: 16860313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.